Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
News
markets
stocks
Norris Medicines Ltd
Norris Medicines Ltd

Norris Medicines Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 546
Jul 14, 2025 Closed
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹17.65
₹-0.30 (-1.67%)
17.50Low
Today’s Performance
18.50High
12.57Low
52 Week’s Performance
27.74High

bt_logoStock Performance

  • 1 Day-1.67%
  • 1 Week5.09%
  • 1 Month-8.56%
  • 3 Months1.99%
  • 6 Months0.73%
  • 1 Year22.11%
  • 3 Years26.25%
  • 5 Years39.98%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.26
  • 52-Week Low (₹)12.57
  • 52-Week High (₹)27.74
  • Price-to-Book (X)*-1.21
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*-14.48
  • Earnings Per Share (₹)-1.24
  • Market Cap (₹ Cr.)*17.95
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Pawan Kalyan Supports Hindi Amid Language War | Sparks Political Firestorm In South3:18Pawan Kalyan Supports Hindi Amid Language War | Sparks Political Firestorm In South
FM Sitharaman: India Has Highest AI Skill Penetration Since 20164:38FM Sitharaman: India Has Highest AI Skill Penetration Since 2016
Air India 171 Crash Tragedy: Human Error Or Hidden System Fault? Key Question Raised3:51Air India 171 Crash Tragedy: Human Error Or Hidden System Fault? Key Question Raised
Vivo X200 FE And X Fold 5: How Is Vivo Winning India? Exclusive With Vikas Tagra6:28Vivo X200 FE And X Fold 5: How Is Vivo Winning India? Exclusive With Vikas Tagra
India’s AI Ambitions Get A Boost From Women In The Workforce : Goldman Sachs #CII2:56India’s AI Ambitions Get A Boost From Women In The Workforce : Goldman Sachs #CII
India’s GCC Evolution: What Got Us Here & What Comes Next? | Anuradha Thakur, DEA Secretary3:44India’s GCC Evolution: What Got Us Here & What Comes Next? | Anuradha Thakur, DEA Secretary
Digital Zones, AI Skilling, Single-Window Clearance Key to GCC Future: Romal Shetty4:51Digital Zones, AI Skilling, Single-Window Clearance Key To GCC Future: Romal Shetty
Tata Power CEO on Surya Ghar Yojana: Taking Solar to Every Home with Financing & Fast Delivery1:50Tata Power CEO On Surya Ghar Yojana: Taking Solar To Every Home With Financing & Fast Delivery
India’s Coffee Boom: CCL MD On New Products, Expansion & Market Strategy20:52India’s Coffee Boom: CCL MD On New Products, Expansion & Market Strategy
Kumar Mangalam Birla Unveils BITS AI+ Campus In Amravati To Lead India’s Tech Education RevolutionKumar Mangalam Birla Unveils BITS AI+ Campus In Amravati To Lead India’s Tech Education Revolution3:19Kumar Mangalam Birla Unveils BITS AI+ Campus In Amravati To Lead India’s Tech Education Revolution
View more

bt_logoFAQ's

What was Norris Medicines Ltd share price previously?
Norris Medicines Ltd share price was down by -1.67% from the previous closing price of ₹17.95.
Who are peers of Norris Medicines Ltd?
The peers of Norris Medicines Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Norris Medicines Ltd?
The promotor/promotors of Norris Medicines Ltd are Vimal D Shah, Praveen Bafna, Angamuthu Vadivel, Priyanka Lohiya, VENKATACHALAM SATHYA.
What has been 52-week high of Norris Medicines Ltd stocks?
The highest price of Norris Medicines Ltd stock is ₹27.74 in the last 52-week.
What is the share price of Norris Medicines Ltd (NORRIS) today on BSE?
As on Jul 14, 2025 Norris Medicines Ltd (NORRIS)’s share price on BSE is Rs 17.65
What is the market cap of Norris Medicines Ltd (NORRIS)?
The current market capitalisation of Norris Medicines Ltd (NORRIS) is 17.95 crores
What is Norris Medicines Ltd Share symbol?
The symbol of Norris Medicines Ltd is .
What is the PE ratio of Norris Medicines Ltd (NORRIS)?
The current PE ratio of Norris Medicines Ltd (NORRIS) is -14.48.
What is the PB ratio of Norris Medicines Ltd (NORRIS)?
The current PB ratio of Norris Medicines Ltd (NORRIS) is -1.21.
Today’s High & Low share prices of Norris Medicines Ltd (NORRIS) on BSE?
Today, the share price of Norris Medicines Ltd (NORRIS) on BSE touched a high of Rs 18.5 and a low of Rs 17.5
What price did Norris Medicines Ltd (NORRIS) shares open on the BSE today?
On BSE, the share price of Norris Medicines Ltd (NORRIS) opened at Rs 18
What is the 52-week high of Norris Medicines Ltd (NORRIS)?
The 52-week high price of Norris Medicines Ltd (NORRIS) is Rs 27.74
What is the 52-week low of Norris Medicines Ltd (NORRIS)?
The 52-week low price of Norris Medicines Ltd (NORRIS) is Rs 12.57

bt_logoAbout Norris Medicines

Norris Medicines Ltd, incorporated in the year 1990, has its registered office in Plot No 801/P & 802, GIDC Industrial Estate, Ankleshwar, Gujarat, 393002, 91-2646-223462/227530, 91-2646-250126. The main industry in which Norris Medicines Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Norris Medicines Ltd is/are Bahedia & Associates. In the main management, is chairman and Priyanka Lohiya is the company secretary for Norris Medicines Ltd.

  • VDS
    Vimal D ShahManaging Director
  • PB
    Praveen BafnaNon Executive Director
  • AV
    Angamuthu VadivelIndependent Director
  • PL
    Priyanka LohiyaCompany Sec. & Compli. Officer
  • VS
    VENKATACHALAM SATHYAAdditional Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.